Jesper Høiland
Fortuna: 41 000 $ al 31/05/2026
Fortuna: 41 000 $ al 31/05/2026
Jesper Høiland is currently Chairman at SciBase Holding AB since 2024, Independent Director at Allarity Therapeutics, Inc. starting 2025, Director at ALK-Abello A, and Head-Strategy at Rani Therapeutics Holdings, Inc. beginning 2026.
Former positions include President, Chief Executive Officer & Director at Radius Health, Inc. from 2017 to 2020; Independent Director at Concert Pharmaceuticals, Inc.; Director at LEO Pharma A; Director at Pharmaceutical Research & Manufacturers of America from 2014 to 2016; Senior Vice President-International Operations at Novo Nordisk A from 2004 to 2012; President at Novo Nordisk, Inc. from 2013 to 2017; Global Chief Commercial Officer & Senior VP at Ascendis Pharma A from 2020 to 2022; Management Consultant at Liseberg AB from 1985 to 1987; General Manager at Novo Nordisk Pharmaceuticals Pty Ltd.; and Senior Vice President at Novo Nordisk North America, Inc. Education includes a graduate degree from Copenhagen Business School conferred in 1985.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 07/01/2026 | 25.000 ( 0,16 % ) | 41 000 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ALK-ABELLÓ A/S | Director/Miembro de la Junta | - |
| SCIBASE HOLDING AB (PUBL) | Presidente | 13/06/2024 |
| ALLARITY THERAPEUTICS, INC. | Director/Miembro de la Junta | 30/06/2025 |
| RANI THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 25/03/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 23/05/2022 |
| RADIUS HEALTH, INC. | Director Ejecutivo | 28/04/2020 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Presidente | 01/03/2017 |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Director/Miembro de la Junta | 01/01/2016 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 15 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
ALK-Abello A/S
ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
SciBase Holding AB
SciBase Holding AB Medical SpecialtiesHealth Technology Develops point of care device for the detection of malignant melanoma | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Novo Nordisk North America, Inc. | |
Liseberg AB | |
Novo Nordisk Pharmaceuticals Pty Ltd.
Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for diabetes care | Health Technology |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Rani Therapeutics Holdings, Inc.
Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.